Statements of Cash Flows - USD ($)	12 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2014
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Income	$ 18,795,517	$ 15,430,383	$ 13,396,769
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	3,297,289	3,544,470	3,817,205
Abandoned patents or software written off	88,796	413,589	250,523
Provision for bad debts	(201,949)	2,475,032	1,806,299
Deferred income tax benefit - net	(4,647,767)	(2,756,517)	(2,682,405)
Loss on disposition of equipment			657,350
Gain on acquisition	(192,999)
Compensatory element of stock issuances	2,006	53,200	223,000
Gain on extinguishment of debt		(394,797)
Stock issued for costs and expenses		$ 109,950	$ 531,825
Stock option exercised	1,755		30,600
(Increase) decrease in operating assets, net:
Accounts, medical and management fee receivables	$ (3,557,507)	$ (4,258,147)	$ (4,044,002)
Notes receivable	28,280	135,592	95,623
Costs and estimated earnings in excess of Billings on uncompleted contracts	681,660	78,149	(314,067)
Inventories	117,549	251,687	(366,448)
Prepaid expenses and other current assets	72,718	67,192	46,967
Other assets	18,054	41,125	131,811
Increase (decrease) in operating liabilities, net:
Accounts payable	(527,957)	(699,555)	(270,482)
Other current liabilities	3,065,673	(1,041,214)	295,219
Customer advances	(739,074)	11,000	68,943
Billings in excess of costs and estimated earnings on uncompleted contracts	64,406
Other Liabilities	242,798	(190,561)	(268,261)
Due to related medical practices	8,121	2,339	3,955
Income tax payable			(19,501)
NET CASH PROVIDED BY OPERATING ACTIVITIES	16,617,369	13,272,917	13,390,923
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment	(712,216)	(131,308)	(620,697)
Cost of acquisition	(4,223,567)
Cost of patents	(113,072)	(139,534)	(214,211)
NET CASH USED IN INVESTING ACTIVITIES	(5,048,855)	(270,842)	(834,908)
CASH FLOWS FROM FINANCING ACTIVITIES:
Repayment of borrowings and capital lease obligations	(3,682,519)	(2,788,401)	(4,400,128)
Repayment of notes receivable from employee stockholders	7,616	7,333	15,992
Distributions to noncontrolling interests	(5,909,100)	(4,627,851)	(4,965,770)
Redemption of noncontroling Interests	(2,905,000)	(1,125,000)	(1,125,100)
Buyout of noncontroling Interest		(4,971,094)
NET CASH USED IN FINANCING ACTIVITIES	(12,489,003)	(13,505,013)	(10,475,006)
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS	(920,489)	(502,938)	2,081,009
CASH AND CASH EQUIVALENTS - BEGINNING OF YEAR	9,448,798	9,951,736	7,870,727
CASH AND CASH EQUIVALENTS - END OF YEAR	$ 8,528,309	$ 9,448,798	$ 9,951,736